Neuropathological Diagnosis of Human Prion Disease

Morphological Studies
  • James W. Ironside
Part of the Methods in Molecular Medicine book series (MIMM, volume 3)

Abstract

The neuropathology of the classical human prion diseases, Creutzfeldt-Jakob dtsease (CJD), Gerstmann-Straussler-Scheinker syndrome (GSS), and kuru, is characterized by four main features* spongiform change, neuronal loss, ghiosts, and amyloid plaque formation (1, 2, 3. These features are shared with prion diseases in animals; the recognition of these similarities prompted the first attempts to transmit a human priori disease (kuru) to a primate in 1966 (4, followed by CJD in 1968 (5) and GSS in 1981 (6). These neuropathological features have formed the basis of the morphological diagnosts of human prion diseases for many years, although it was recognized that these changes are enormously variable both from case to case and within the central nervous system (CNS) in individual cases (7). In this respect, it is interesting to note that the original case reported by Creutzfeldt (8, 9) and two of the original cases reported by Jakob (10, 11, 12) do not show any of these characteristic neuropathological features; the diagnosis in these cases remains uncertain on review (7, 13). However, at least two of Jakob’s original cases show typical neuropathological changes and other cases subsequently reported from his laboratory (including the members of the Backer family) also exhibited classical histological features (12, 14). It is also of interest to note that prion protein (PrP) gene analysis has recently been performed on one of the Backer family cases, showing a codon 178 Asn mutation with met/val at codon 129 (15. This genotype has been described in other familial forms of human prion disease (16 (see Chapter 2).

Keywords

Fatigue Formalin Phenol Codon Dementia 

References

  1. 1.
    Bastian, F. O. (ed.) (1991) Creutzfeldt-Jakob Dzseuse and Other Trunsmrssrble Human Sponglform Encephafopathles. Mosby Year Book, St. Louis, MOGoogle Scholar
  2. 2.
    Bell, J. E. and Ironside, J. W. (1993) Neuropathology of spongiform encepha-lopathles in humans. Br Med. Bull 49, 738–777PubMedGoogle Scholar
  3. 3.
    Tomlinson, B. E. (1992) Ageing and the dementias, in Greenfield’s Neuropathology, 5th ed. (Adams, J. H. and Duchen, L.W., eds.), Edward Arnold, London, pp 1284–1410Google Scholar
  4. 4.
    Gajdusek, D. C., Gibbs, C. J., and Alpers, M. P. (1966) Experimental transmission of a kuru-like syndrome in chimpanzees. Nature 209, 794–796PubMedCrossRefGoogle Scholar
  5. 5.
    Gibbs, C. J., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Beck, E., Daniel, P. M., et al. (1968) Creutzfeldt-Jakob disease (subacute sponglform encepha-lopathy): transmission to the chimpanzee. Science 161, 388–389PubMedCrossRefGoogle Scholar
  6. 6.
    Masters, C. L., Gajdusek, D. C., and Gibbs, C. J. (1981) Creutzfeldt-Jakob dis-ease: virus isolations from the Gerstmann-Straussler syndrome. Bram 104, 559–588.CrossRefGoogle Scholar
  7. 7.
    Richardson, E. P., Jr. and Masters, C. L. (1995) The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Brarn Pathol 5, 33–41CrossRefGoogle Scholar
  8. 8.
    Creutzfeldt, H. G. (1920) Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z. ges Neural Psychlat 57, 1–18CrossRefGoogle Scholar
  9. 9.
    Creutzfeldt, H. G. (1921) Uber eine elgeartlge herdformige Erkrankung des Zentralnervensystems, in Htstologische und Histopathologuche Arbeiten uber dre Grosshirnrinde (Nissl, F. and Alzheimer, A., eds.), Gustav Fischer, Jena, pp 1–48.Google Scholar
  10. 10.
    Jakob, A. (1921) Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde. Z ges Neural Psychrat 64, 147–228CrossRefGoogle Scholar
  11. 11.
    Jakob, A. (1921) Uber eine der multiplen sklerose klinische nahestehende Erkrankung des Zentralnervensystems (spastische Pseudosklerose) mit bemerkensweitem anatomischem Befunde. Med Klinik 17, 372–376.Google Scholar
  12. 12.
    Jakob, A. (1923) Spastische Pseudosklerose, in Monographien aus dem Gesamtgebrete der Neurologie und Psychiatrie, Die Extrapyramidalen Erkrankungen (Foester, O. and Wilmanns, K., eds.), Springer, Berlm, 37, 212–245Google Scholar
  13. 13.
    Masters, C. L., and Gajdusek, D. C. (1982) The spectrum of Creutzfeldt-Jakob disease and the virus-induced spongiform encephalopathtes, in Recent Advances in Neuropathology, vol 2 (Smith, W. T. and Canavagh, J. B., eds), Churchill Livingsione, EdinburghGoogle Scholar
  14. 14.
    Meggendorfer, F. (1930) Klinische und genealogtsche beobachtungen bei einem Fall von spastischer Pseudosklerose Jakobs. Z gesNeurol Psychlat 128, 337–341Google Scholar
  15. 15.
    Brown, P., Cervenakova, L., Boellaard, J. W., Stavrou, D., Goldfarb, L. G., and Gajdusek, D. C. (1994) Identification of a PRNP gene mutation in Jakob’s original Creutzfeldt-Jakob disease family. Lancet 344, 130–131PubMedCrossRefGoogle Scholar
  16. 16.
    Nieto, A., Goldfarb, L. G., Brown, P., McCombte, W. R., Trapp, S., Asher, D. M., et al (1991) Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet 337, 622–623PubMedCrossRefGoogle Scholar
  17. 17.
    Prusmer, S. B. and DeArmond, S. J. (1991) Molecular biology and pathology of scrapte and the prion diseases of humans. Brain Pathol 1, 297–309CrossRefGoogle Scholar
  18. 18.
    DeArmond, S. L. (1993) Overview of the transmissible spongiform encepha-lopathtes: prion protein disorders. Br Med Bull 49, 725–737.PubMedGoogle Scholar
  19. 19.
    Baker, H. F. and Ridley, R. M. (1992) The genetics and transmissibility of human spongtform encephalopathy. Neurodegeneration 1, 3–16.Google Scholar
  20. 20.
    Tatelshi, J. and Kitamoto, T. (1995) Inherited prion diseases and transmission to rodents. Brain Pathol 5, 53–59CrossRefGoogle Scholar
  21. 21.
    Ridley, R. M. (1994) Perceptions of prion disease. J Chin Pathol 47, 876–879CrossRefGoogle Scholar
  22. 22.
    Metters, J. S. (1992) Neuro and ophthalmic surgery procedures in patients with, or suspected to have, or at risk of developing CJD or GSS. Letter PL(92)CO/4 to Consultants and Health Managers Department of Health, LondonGoogle Scholar
  23. 23.
    Brown, P. and Cathala, F. (1979) Creutzfeldt-Jakob disease in France I Retro-spective study of the Paris area during the ten year period 1968–1977. Ann Neurol 5, 189–192PubMedCrossRefGoogle Scholar
  24. 24.
    Advisory Committee on Dangerous Pathogens (1994) Precautzons for Work with Human and Animal Transmisslble Spongiform Encephalopathles. HMSO, LondonGoogle Scholar
  25. 25.
    Bell, J. E. and Ironside, J. W. (1993) How to tackle a possible Creutzfeldt-Jakob disease necropsy. J Clan Pathol 46, 193–197CrossRefGoogle Scholar
  26. 26.
    Klatzo, I., Gajdusek, D. C., and Vegas, V. (1959) Pathology of kuru Lab Invest 8, 799–8PubMedGoogle Scholar
  27. 27.
    Will, R. G. (1991) The spongtform encephalopathies. J Neurol Neurosurg Psychiat 54, 761–763PubMedCrossRefGoogle Scholar
  28. 28.
    Brown, P., Wolff, A., and Gajdusek, D. C. (1990) A simple and effective method for inactlvating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40, 887–890PubMedGoogle Scholar
  29. 29.
    Masters, C. L. and Richardson, E. P. (1978) Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101, 333–334PubMedCrossRefGoogle Scholar
  30. 30.
    Sasaki, A., Hirato, J., and Nakazato, Y. (1993) Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol 86, 337–344PubMedCrossRefGoogle Scholar
  31. 31.
    Miyazono, M., Iwaki, T., Kitamoto, T., Kaneko, Y., Doh-ura, K., and Tateishi, J. (1991) A comparative imununohistochemical study of kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque forma-tion. Am J Pathol 139, 589–598.PubMedGoogle Scholar
  32. 32.
    Will, R. G. and Matthews, W. B. (1984) A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79 I. Clinical features. J Neural Neurosurg Psychiat. 47, 134–140CrossRefGoogle Scholar
  33. 33.
    Mizutam, T. and Shiraki, H. (eds) (1985) Clinicopathological Aspects of Creutzfeldt-Jakob Disease Elsevier, Amsterdam.Google Scholar
  34. 34.
    Mori, S., Hamada, C., Kumamshi, T., Fukuhara, N., Ichihashi, Y., Ikuta, F., et al. (1989) A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the ‘panencephalopathic type’ disease. Neurology 39, 1337–1342PubMedGoogle Scholar
  35. 35.
    Pickering-Brown, S., Mann, D. M. A., Owen, F., Ironside, J. W., de Silva, R., Roberts, D. A., et al. (1995) Allelic variations in apolipoprotein E and prion pro-tem genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosct Lett 187, 127–129CrossRefGoogle Scholar
  36. 36.
    Frackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., and Wang, K. C. (1992) Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol 84, 225–233PubMedCrossRefGoogle Scholar
  37. 37.
    Bugiam, O., Giaccone, G., Verga, L., Pollo, B., Frangione, B., Farlow, M. R., et al. (1993) βPP participates in PrP-amyloid plaques of Gerstmann-Straussler-Scheinker disease, Indiana kindred. J. Neuropathol Exp Neural 52, 66–70Google Scholar
  38. 38.
    Miyazono, M., Kitamoto, T., Iwaki, T., and Tateishi, J. (1992) Colocalization of prion protein and A4β protein in the same amyloid plaques in patients with Gerstmann-Straussler syndrome. Acta Neuropathol 83, 333–339PubMedCrossRefGoogle Scholar
  39. 39.
    Martinez-Lage, J. F., Poza, M., Sola, J., Tortosa, J. G., Brown, P., Cervenakova, L., et al. (1994) Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. J Neural Neurosurg. Psychiat 57, 1091–1094CrossRefGoogle Scholar
  40. 40.
    Weller, R. O., Steart, P. V., and Powell-Jackson, J. D. (1986) Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hor-mone administration. Neuropathol. Appl Neurobiol 12, 117–129PubMedCrossRefGoogle Scholar
  41. 41.
    Gibbs, C. J., Joy, A., Heffner, R., Franko, M., Miyazaki, M., Asher, D., et al. (1985) Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313, 734–738PubMedCrossRefGoogle Scholar
  42. 42.
    Billette de Villemeur, T., Gelottt, A., Deslys, J. P., Dormont, D., Duyckaerts, C., Jardm, L., et al. (1994) Iatrogenic Creutzfeldt-Jakob disease in three growth hor-mone recipients: a neuropathological study. Neuropathol Appl Neurobtol 20, 111–117CrossRefGoogle Scholar
  43. 43.
    Goodbrand, I. A., Ironside, J. W., Nicolson, D., and Bell, J. E. (1995) Prion pro-tein accumulation in the spinal cords of patients with sporadic and growth hormone associated Cruetzfeldt-Jakob disease. Neuroscz Lett 183, 127–130.CrossRefGoogle Scholar
  44. 44.
    Gajdusek, D. C. and Zigas, V. (1957) Degenerative disease of the central nervous system in New Guinea The endemic occurrence of “kuru” in the native population. N Engl J Med 257, 974–978PubMedCrossRefGoogle Scholar
  45. 45.
    Neumann, M. A., Gajdusek, D. C., and Zigas, V. (1965) Neuropathologic find-ings in exotic neurologic disorders among natives of the highlands of New Gumea. J Neuropathol Exp Neurol 18, 486–507.Google Scholar
  46. 46.
    Gerstmann, J., Straussler, E., and Schemker, I. (1936) Uber eine etgenarttge heredrtar-familiare Erkrankung des Zentralnervensystems, zugletch ein Beitrag zur Frage des vorzetttgen lokalen Alterns. Z ges Neurol Psychzat 154, 736–762CrossRefGoogle Scholar
  47. 47.
    Ghetti, B., Dlouhy, S. R., Glaccone, G., Buglam, O., Frangione, B., Farlow, M. R., et al (1995) Gerstmann-Straussler-Schemker disease and the Indiana kindred. Bram Pathol 5, 61–75CrossRefGoogle Scholar
  48. 48.
    Gutroy, D. C., Yanagihara, R., and Gajdusek, D. C. (1991) Localisation of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amylotdoses. Acta Neuropathol 82, 87–92CrossRefGoogle Scholar
  49. 49.
    Brown, P., Gibbs. C. J., Jr., Rogers-Johnson, P., Asher, D. M., Sulima, M. P., Bacote, A., et al (1994) Human spongtform encephalopathy the National Instt-tutes of Health series of 300 experimentally transmitted disease. Ann Neurof 35, 513–529CrossRefGoogle Scholar
  50. 50.
    Ghetto, B., Taghavina, F., Masters, C. L., Beyreuther, K., Giaccone, G., Verga, L., et al. (1989) Gerstmann-Straussler-Schemker disease II. Neurofibrillary tangles and plaques with PrP amyloid coexist in an affected family. Neurology 39, 1453–1461Google Scholar
  51. 51.
    Medort, R., Tritschler, J. H., LeBlanc, A., Vtllare, F., Manetto, V., Ghen, H. Y., et al (1992) Fatal familial insonima, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 7, 444–449CrossRefGoogle Scholar
  52. 52.
    Collinge, J., Owen, F., Poulter, M., Leach, M., Crow, T. J., Rossor, M. N., et al (1990) Prion dementia without characteristtc pathology. Lancet 336, 7–9PubMedCrossRefGoogle Scholar
  53. 53.
    Manetto, V., Medori, R., Cortelli, P., Montagna, P., Tinuper, P., Baruzzi, A., et al (1992) Fatal familial insomnia. clintcal and pathological study of five new cases Neurology 42, 312–319PubMedGoogle Scholar
  54. 54.
    Gambetti, P., Parchr, P., Petersen, R. B., Chen, S. G., and Lugaresi, E. (1995) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, patho-logical and molecular features. Brazn Pathol 5, 43–51CrossRefGoogle Scholar
  55. 55.
    Collinge, J., Palmer, M. S., Sidle, K. C., Gowland, I., Medori, R., Ironside, J., and Lantos, P. (1995) Transmission of fatal familial insomnia to laboratory animals. Lancet 346, 569,570PubMedCrossRefGoogle Scholar
  56. 56.
    Lantos, P. L., McGill, I. S., Janota, I., Doey, L. J., Collinge, J., Bruce, M., et al (1992) Prion protein immunocytochemistry helps to establish the true incidence of prion diseases. Neurosci. Lett. 147, 67–71.PubMedCrossRefGoogle Scholar
  57. 57.
    Editortal (1990) Prion disease-spongiform encephalopathies unveiled. Lancet 336, 21–22CrossRefGoogle Scholar
  58. 58.
    Nakazato, Y., Htrato, J., Ishida, Y., Hoshi, S., Hasegawa, M., and Fukuda, T. (1990) Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phospho-rylated neurotilament epttope. J Neuropathol Exp Neural 49, 197–205CrossRefGoogle Scholar
  59. 59.
    Kato, S., Hirano, A., Umahara, T., Llena, J. F., Herz, F., and Ohama, E. (1992) Ultrastructural and immunohistological studies of ballooned cortical neurons in Creutzfeldt-Jakob disease expression of αB-crystallin, ubtquitin and stress-response protein 27. Acta Neuropathol 84, 443–448PubMedGoogle Scholar
  60. 60.
    Tateishi, J., Kitamoto, T., Doh-Ura, K., Boellaard, J. W., and Peiffer, J. (1992) Creutzfeldt-Jakob disease with amyloid angiopathy: diagnosis by immunologic analysis and transmission experiments. Acta Neuropathol 83, 559–563PubMedCrossRefGoogle Scholar
  61. 61.
    Gray, F., Chretien, F., Cesaro, P., Chatelam, J., Beaudry, P., Laplanche, J. L., et al (1994) Creutzfeldt-Jakob disease and cerebral amyloid angiopathy. Acta Neuropathol 88, 106–111PubMedCrossRefGoogle Scholar
  62. 62.
    Powers, J. M., Liu, Y., Hair, L. S., Kascsack, R. J., Lewis, L. D., and Levy, L. A. (1991) Concomitant Creutzfeldt and Alzheimer diseases. Acta Neuropathol 83, 95–98PubMedCrossRefGoogle Scholar
  63. 63.
    Ironside, J. W., McCardle, L., Hayward, P. A. R., and Bell, J. E. (1993) Ubiqutin immunocytochemistry in human spongiform encephalopathies. Neuropathol Appl Neuroblol 19, 134–140CrossRefGoogle Scholar
  64. 64.
    Laszlo, L., Lowe, J., Self, T., Kenward, N., Landon, M., McBride, T. et al (1992) Lysosomes as key organelles in the pathogenesis of prion encephalopthies J Pathol 166, 333–341PubMedCrossRefGoogle Scholar
  65. 65.
    Hansen, L. A., Mashah, E., Terry, R. D., and Mirra, S. S. (1989) A neuropatho-logical subset of Alzheimer’s disease with concomitant Lewy body disease and spongiform change Acta Neuropathol 78, 194–201PubMedCrossRefGoogle Scholar
  66. 66.
    Collinge, J., Palmer, M. S., and Dryden, A. J. (1991) Genetic predisposition to iatrogetuc Creutzfeldt-Jakob disease Lancet 337, 1441,1442CrossRefGoogle Scholar
  67. 67.
    de Silva, R., Ironside, J. W., McCardle, L., Esmonde, T., Bell, J. E., Will, R. G., et al. (1994) Neuropathological phenotype and “priori protein” genotype correlation in sporadic Creutzfeldt-Jakob disease. Neuroscz Lett 179, 50–52CrossRefGoogle Scholar
  68. 68.
    Amouyel, P., Vidal, O., Launay, J. M., and Laplanche, J. L. (1994) The apoltpoprotein E alleles as major susceptibility factors for Creuztfeldt-Jakob dis-ease. Lancet 344, 1315–1318.PubMedCrossRefGoogle Scholar
  69. 69.
    Hayward, P. A. R., Bell, J. E., and Ironside, J. W. (1994) Prion protein immuno-cytochemistry the development of reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neuroblol 20, 375–383CrossRefGoogle Scholar
  70. 70.
    Sutherland, K., Barrie, C., and Ironside, J. W. (1994) Automattc quantification of amyloid plaque formation in human spongiform encephalopathy. Neurodegeneratron 3, 293–300Google Scholar
  71. 71.
    Turner, C., Bell, J. E., and Ironstde, J. W. (1993) Localisation of microglia in CNS amyloid plaques an imrmunocytochemical and confocal microscopic study. J Pathol 170, 401.Google Scholar
  72. 72.
    Liberski, P. P., Budka, H., Sluga, E., and Barcikowska Kwiecmski, H. (1992) Tubulo-vesicular structures in Creutzfeldt-Jakob disease. Acta Neuropathol 84, 238–243.PubMedCrossRefGoogle Scholar
  73. 73.
    Liberski, P. P., Yanagihara, R., Gibbs, C. J., and Gajdusek, D. C. (1990) Appear-ance of tubulovestcular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Acta Neuropathol 79, 349–354.PubMedCrossRefGoogle Scholar
  74. 74.
    DeArmond, S. J. (1993) Alzheimer’s disease and Creutzfeldt-Jakob disease over-lap of pathogenic mechanisms. Curr Open Neural 6, 872–881CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1996

Authors and Affiliations

  • James W. Ironside
    • 1
  1. 1.Neuropathology Laboratory, National CJD Surveillance Unit, Department of PathologyUniversity of Edinburgh, Western General HospitalEdinburghUK

Personalised recommendations